Rochester, MNNCT04344769Now EnrollingIRB Ready

Autosomal Dominant Polycystic Kidney Disease Clinical Trial in Rochester, MN

Access cutting-edge autosomal dominant polycystic kidney disease treatment through this clinical trial at a research site in Rochester. Study-provided care at no cost to qualified participants.

Sponsored by Mayo Clinic

Quick Self-Assessment

See if you qualify for this Rochester location

Preparing your pre-screening questions…

Expert Care in Rochester

Access autosomal dominant polycystic kidney disease specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related autosomal dominant polycystic kidney disease treatment provided free

Apply for This Rochester Location

Check if you qualify for this autosomal dominant polycystic kidney disease clinical trial in Rochester, MN

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Rochester

    Convenient for MN residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Rochester site if eligible
  4. 4Begin participation

About This Autosomal Dominant Polycystic Kidney Disease Study in Rochester

The purpose of this study is to characterize oxidative stress and the Nrf2 antioxidant response in early stages of Autosomal Dominant Polycystic Kidney Disease (ADPKD), while identifying candidate biomarkers.

Sponsor: Mayo Clinic

Who Can Participate

Inclusion Criteria

(ADPKD Subjects):
ADPKD (based on Ravine et al. criteria)
Class 1 B-E according to our imaging classification
Male and female subjects 18 - 30 years of age, inclusive
Estimated GFR\> 60 mL/min/m2 (CKD-EPI equation)
Ability to provide written, informed consent.

Exclusion Criteria

(ADPKD Subjects):
Class 2 according to our imaging classification
Concomitant systemic disease in the kidney (e.g. lupus, hepatitis B or C, amyloidosis)
Diabetes mellitus (fasting glucose \> 126 mg/dL or treatment with insulin or oral hypoglycemics).
Predicted urine protein excretion in urinalysis \>1 g/24 hrs
Abnormal urinalysis suggestive of concomitant glomerular disease.
Subjects having contraindications to, or interference with MRI assessments. \[For example: ferromagnetic metal prostheses, aneurysm clips, severe claustrophobia, large abdominal/back tattoos, etc\].
Female subjects that are pregnant Inclusion Criteria (Healthy Subjects):
Male and female subjects 18 - 30 years of age, inclusive
Estimated GFR\> 60 mL/min/m2 (CKD-EPI equation)
Ability to provide written, informed consent. Exclusion Criteria (Healthy Subjects):
Previous personal or family history of kidney disease.
Concomitant systemic disease in the kidney (e.g. lupus, hepatitis B or C, amyloidosis)
Diabetes mellitus (fasting glucose \> 126 mg/dL or treatment with insulin or oral hypoglycemics).
Presence of proteinuria
Abnormal urinalysis suggestive glomerular disease.
Subjects having contraindications to, or interference with MRI assessments. \[For example: ferromagnetic metal prostheses, aneurysm clips, severe claustrophobia, large abdominal/back tattoos, etc\]
Female subjects that are pregnant

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Rochester?

Yes, this clinical trial (NCT04344769) has an active research site in Rochester, MN that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Autosomal Dominant Polycystic Kidney Disease Treatment Options in Rochester, MN

If you're searching for autosomal dominant polycystic kidney disease treatment options in Rochester, MN, this clinical trial (NCT04344769) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Rochester research site is actively enrolling participants for this clinical trial. You'll receive care from experienced autosomal dominant polycystic kidney disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all autosomal dominant polycystic kidney disease clinical trials near you to find additional studies recruiting in your area.

More Heart Attack Trials in Rochester, MN

See all heart attack clinical trials recruiting in Rochester — not just this study.

Browse Heart Attack Trials in Rochester →

Browse More Trials by Condition

Heart Attack TrialsAnkylosing Spondylitis TrialsInterstitial Cystitis TrialsPolycystic Kidney Disease TrialsMyocardial Infarction TrialsAll Conditions →

Ready to Join in Rochester?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Rochester, MN